e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

17.46 -0.12 (-0.68%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Novocure Reports Surprise Loss As Revenue Falls Short ↗

April 29, 2021

Novocure reported a surprise loss as the cancer-fighting medtech missed on revenue. NVCR stock fell.

Via Investor's Business Daily

Recap: NovoCure Q1 Earnings ↗

April 29, 2021

Shares of NovoCure (NASDAQ:NVCR) fell 2.7% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 200.00% year over...

Via Benzinga

Novocure Reports First Quarter 2021 Financial Results and Provides Company Update

April 29, 2021

From Novocure

Via Business Wire

Earnings Scheduled For April 29, 2021 ↗

April 29, 2021

Companies Reporting Before The Bell • OSI Systems (NASDAQ:OSIS) is estimated to report quarterly earnings at $1.33 per share on revenue of $290.51 million. •...

Via Benzinga

London Cancel ↗

April 26, 2021

Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon.

Via Talk Markets

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

Earth Day ↗

April 22, 2021

Once again the exchanges are unsure if they want to go up or down.

Via Talk Markets

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

Novocure Announces FDA IDE Approval and Steering Committee for KEYNOTE-B36 Trial Evaluating Tumor Treating Fields Together with Pembrolizumab in Non-Small Cell Lung Cancer

April 22, 2021

From Novocure

Via Business Wire

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark ↗

April 21, 2021

Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member.

Via Investor's Business Daily

Is Novocure a Buy? ↗

April 20, 2021

Once a stock goes up 50% in a single day, it can be hard to keep the momentum going.

Via The Motley Fool

Why Investors Are So Excited About Novocure ↗

April 20, 2021

The company's Tumor Treating Fields therapy looks very promising in treating lung cancer.

Via The Motley Fool

Currency Manipulation ↗

April 16, 2021

London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53.

Via Talk Markets

This Stock Just Popped 40%. Here's Why It Can Continue to Crush the Market ↗

April 16, 2021

Novocure has provided stellar returns over the last five years, now up 17 times. Recent positive news may keep its stock going up.

Via The Motley Fool

Stock Market Rally Keeps Rising As Treasury Yields Fall Despite Strong Earnings, Economic Data; Goldman, Nvidia, Coinbase In Focus ↗

April 16, 2021

Tumbling yields and strong economic data fueled stocks. Goldman earnings, Nvidia news and the Coinbase IPO were in focus.

Via Investor's Business Daily

Topics Initial Public Offering Stocks

Happy News Day ↗

April 15, 2021

The stock markets are in clover because March retail sales hit 9.8% according to the Department of Commerce.

Via Talk Markets

Stunning Market Debut ↗

April 14, 2021

Wednesday brought a zip into the accounts of many financial stocks thanks to a boom result from Goldman Sachs GS, which boosted its competitors' prices.

Via Talk Markets

Cancer Therapy Novocure Stock Flashes Renewed Technical Strength ↗

April 14, 2021

Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 14, 2021

Gainers Akumin (NASDAQ:AKU) shares increased by 13.54% to $3.52 during Wednesday's pre-market session. The market value of their outstanding shares is at $247.0...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

April 14, 2021

JP Morgan raised Southwest Airlines Co. (NYSE: LUV) price target from $44 to $66. Southwest Airlines shares rose 1% to $63.79 in pre-market trading. Keybanc boosted Public...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021 ↗

April 14, 2021

Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to...

Via Benzinga

Electric Cancer Cure ↗

April 13, 2021

Most US stocks were down on fear of inflation and financial risks but then rose after lunch.

Via Talk Markets

The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead ↗

April 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (...

Via Benzinga

Why Novocure Stock Skyrocketed Today ↗

April 13, 2021

The oncology specialist's investigational cancer treatment could be a game-changer.

Via The Motley Fool

50 Biggest Movers From Yesterday ↗

April 14, 2021

Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 75 Points; vTv Therapeutics Shares Spike Higher ↗

April 13, 2021

Toward the end of trading Tuesday, the Dow traded down 0.22% to 33,669.76 while the NASDAQ rose 0.80% to 13,960.92. The S&P also rose, gaining 0.28% to 4,139.55. The U.S. has...

Via Benzinga

Topics Stocks

What's Going On With NVCR Stock And VTV Stock Today? ↗

April 13, 2021

Novocure Ltd (NASDAQ: NVCR) shares are trading higher after a data monitoring committee said the interim analysis of the company's Phase 3 LUNAR trial would be accelerated....

Via Benzinga

Stocks Mixed Following JNJ Vaccine Update, Inflation Data ↗

April 13, 2021

The Dow is off more than 100 points. The S&P 500 notched a new intraday high.

Via Talk Markets

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 13, 2021

Gainers NovoCure (NASDAQ:NVCR) shares rose 42.08% to $187.38 during Tuesday's regular session. Trading volume for NovoCure's stock is 11.4 million as of 12:32 EST...

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy